Prior authorisation: difference between revisions
Diff·revision 19 → 20·01:47, 20 Sep 2025
Difference between revision 19 and revision 20 of Prior authorisation. 2 lines changed; the page grew by 135 bytes.
| Revision 19 — 08:48, 2 Sep 2025 OffLabelOdile (talk) close an unbalanced quotation mark 4,081 bytes ±0 | Revision 20 — 01:47, 20 Sep 2025 TSH_Tallulah (talk) add the note that price is not a proxy for quality 4,216 bytes +135 | ||
|---|---|---|---|
| 38 | Coverage of weight-management indications differs from coverage of diabetes indications for the same molecule in many systems, so status can depend on the indication rather than the drug.{{r|kyle2021}} | 38 | Coverage of weight-management indications differs from coverage of diabetes indications for the same molecule in many systems, so status can depend on the indication rather than the drug.{{r|kyle2021}} |
| 39 | 39 | ||
| + | 40 | International differences in coverage are one component of the broader pattern described at [[Global access disparity]].{{r|ada2024}} | |
| + | 41 | ||
| 40 | == References == | 42 | == References == |
| 41 | {{reflist}} | 43 | {{reflist}} |